Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Hydroxyapatite 830 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxyapatite 3.32 g oral granules sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing durapatite (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing calcium hydroxyapatite and carboxymethylcellulose sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carboxymethylcellulose sodium + hydroxyapatite injectable implant 1mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing calcium hydroxyapatite |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Calcium hydroxyapatite microsphere suspension in aqueous based carrier 0.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Calcium hydroxyapatite microsphere suspension in aqueous based carrier 1.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Calcium hydroxyapatite crystal |
Is modification of (attribute) |
False |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxyapatite only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydroxyapatite-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only durapatite in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carmellose- and hydroxyapatite-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Carmellose and hydroxyapatite only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Carmellose- and hydroxyapatite-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Carmellose and hydroxyapatite only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydroxyapatite 830 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydroxyapatite 830 mg oral tablet |
Has precise active ingredient |
True |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydroxyapatite 3.32 g oral granules sachet |
Has basis of strength substance (attribute) |
True |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydroxyapatite 3.32 g oral granules sachet |
Has precise active ingredient |
True |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing durapatite (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydroxyapatite-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydroxyapatite only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |